中国病理生理杂志
中國病理生理雜誌
중국병리생리잡지
CHINESE JOURNAL OF PATHOPHYSIOLOGY
2015年
5期
882-887
,共6页
童嘉琦%吴萍%黄欣%赖沛龙%耿素霞%翁建宇%杜欣
童嘉琦%吳萍%黃訢%賴沛龍%耿素霞%翁建宇%杜訢
동가기%오평%황흔%뢰패룡%경소하%옹건우%두흔
间充质干细胞%调节性树突状细胞%急性移植物抗宿主病
間充質榦細胞%調節性樹突狀細胞%急性移植物抗宿主病
간충질간세포%조절성수돌상세포%급성이식물항숙주병
Mesenchymal stem cells%Regulatory dentritic cells%Acute graft-versus-host disease
目的:观察间充质干细胞诱导的CD8α+Jagged2high CD11bhigh调节性树突状细胞(MSC-DCregs),对小鼠急性移植物抗宿主病(aGVHD)的影响。方法:体外诱导MSC-DCregs。以C57BL/6(H-2b)小鼠为供鼠、接受清髓性全身照射(TBI)预处理的BALB/c (H-2d)小鼠为受鼠进行移植。分为以下5组:为正常对照组;TBI组;移植组:移植物为1×107骨髓细胞( BMCs);aGVHD组:移植物为1×107 BMCs+1×107脾细胞( SpCs);MSC-DCregs组:移植物为1×107 BMCs+1×107 SpCs+1×106 MSC-DCregs。监测植入情况、H2-Kb嵌合率、aGVHD评分、生存和病理学改变。结果:处理10 d后所有小鼠造血恢复,30 d后嵌合率检测转为供鼠型。 aGVHD组和MSC-DCregs组中位生存期分别为27 d和33 d,MSC-DCregs组生存期较aGVHD组延长(P<0.01),临床评分比aGVHD组低(P<0.01),33 d的皮肤、肝脏病理学改变均优于aGVHD组。结论: MSC-DCregs具有防治aGVHD的作用,其相关作用机理待进一步研究。
目的:觀察間充質榦細胞誘導的CD8α+Jagged2high CD11bhigh調節性樹突狀細胞(MSC-DCregs),對小鼠急性移植物抗宿主病(aGVHD)的影響。方法:體外誘導MSC-DCregs。以C57BL/6(H-2b)小鼠為供鼠、接受清髓性全身照射(TBI)預處理的BALB/c (H-2d)小鼠為受鼠進行移植。分為以下5組:為正常對照組;TBI組;移植組:移植物為1×107骨髓細胞( BMCs);aGVHD組:移植物為1×107 BMCs+1×107脾細胞( SpCs);MSC-DCregs組:移植物為1×107 BMCs+1×107 SpCs+1×106 MSC-DCregs。鑑測植入情況、H2-Kb嵌閤率、aGVHD評分、生存和病理學改變。結果:處理10 d後所有小鼠造血恢複,30 d後嵌閤率檢測轉為供鼠型。 aGVHD組和MSC-DCregs組中位生存期分彆為27 d和33 d,MSC-DCregs組生存期較aGVHD組延長(P<0.01),臨床評分比aGVHD組低(P<0.01),33 d的皮膚、肝髒病理學改變均優于aGVHD組。結論: MSC-DCregs具有防治aGVHD的作用,其相關作用機理待進一步研究。
목적:관찰간충질간세포유도적CD8α+Jagged2high CD11bhigh조절성수돌상세포(MSC-DCregs),대소서급성이식물항숙주병(aGVHD)적영향。방법:체외유도MSC-DCregs。이C57BL/6(H-2b)소서위공서、접수청수성전신조사(TBI)예처리적BALB/c (H-2d)소서위수서진행이식。분위이하5조:위정상대조조;TBI조;이식조:이식물위1×107골수세포( BMCs);aGVHD조:이식물위1×107 BMCs+1×107비세포( SpCs);MSC-DCregs조:이식물위1×107 BMCs+1×107 SpCs+1×106 MSC-DCregs。감측식입정황、H2-Kb감합솔、aGVHD평분、생존화병이학개변。결과:처리10 d후소유소서조혈회복,30 d후감합솔검측전위공서형。 aGVHD조화MSC-DCregs조중위생존기분별위27 d화33 d,MSC-DCregs조생존기교aGVHD조연장(P<0.01),림상평분비aGVHD조저(P<0.01),33 d적피부、간장병이학개변균우우aGVHD조。결론: MSC-DCregs구유방치aGVHD적작용,기상관작용궤리대진일보연구。
AIM:To investigate the role of mesenchymal stem cell-induced regulatory dendritic cells ( MSC-DCregs) in mouse acute graft-versus-host disease( aGVHD) model.METHODS: Bone marrow cells from BALB/c ( H-2 d ) mice were isolated and were induced to differentiate into DCs.The DCs were selected by flow cytometry, and after 10 d co-culture with MSCs, they were induced to be MSC-DCregs.Male 8-week-old C57BL/6 (H-2b) mice were used as do-nor mice.The female 8-week-old BALB/c (H-2d) mice, who had received 100 cm source-skin distance, 30 cm ×30 cm radiation field, 700 cGy total body irradiation (TBI) pretreatment were used as recipient mice.The recipients were divided into 5 groups:control group, TBI group ( injected with medium only) , bone marrow transplantation group ( injected with 1 ×107 bone marrow cells), aGVHD group (injected with 1 ×107 bone marrow cells and 1 ×107 spleen cells), and MSC-DCregs group (injected with 1 ×107 bone marrow cells, 1 ×107 spleen cells and 1 ×106 MSC-DCregs).The white blood cell count, recipients’ chimerism, clinical evaluation of aGVHD, survival analysis and pathological changes were deter-mined.RESULTS:Hematopoieic recovery was seen at 10 d after transplantation.The recipients’ chimerism was parallel to the donors’ at 30 d.The median survival time of the mice in aGVHD group and MSC-DCregs group was 27 d and 33 d, and the survival rates at 30 d were 20% and 100% (P<0.01), respectively.The clinical scores of the mice in MSC-DCregs group were lower than those in aGVHD group ( P<0.01) .Moreover, the pathological changes in the skin and liver of the mice in MSC-DCregs group were less serious than those in aGVHD group.CONCLUSION: The MSC-DCregs in-duce an aGVHD tolerance in vivo, and further research of its mechanism is still in great necessary.